Skip to main content
SpringerLink
Log in

Detection of Illicit Use of Opioids in Primary Care

  • Chapter
Opioids in Medicine

  • 1871 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Center on Addiction and Substance Abuse at Columbia University Missed Opportunity: CASA National Survey of Primary Care Physicians and Patients on Substance Abuse, 2000: New York.

    Google Scholar 

  2. Schnoll, S.H. and J. Finch, Medical education for pain and addiction: making progress towards answering a need. J Law Med Ethics, 1994. 22: pp. 252–256.

    Article  PubMed  CAS  Google Scholar 

  3. Weissman, D.E. and J.D. Haddox, Opioid pseudoaddiction – an iatrogenic syndrome. Pain, 1989. 36: pp. 363–366.

    Article  PubMed  CAS  Google Scholar 

  4. Savage, S., et al., A consensus document from the American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine. Definitions related to the use of opioids for the treatment of pain, 2001.

    Google Scholar 

  5. Portenoy, R.K. and S.R. Savage, Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy – tolerance and addiction. J Pain Symptom Manage, 1997. 14: pp. S27–S35.

    Article  PubMed  CAS  Google Scholar 

  6. Hardman, J.G., L.E. Limbird, and A.G. Gilman, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, L.S. Goodman and A.G. Gilman, Editors, 2001, McGraw Hill: New York.

    Google Scholar 

  7. Schnoll, S.H. and M.F. Weaver, Addiction and pain. Am J Addict, 2003. 12(Suppl 2): pp. S27–S35.

    Article  PubMed  Google Scholar 

  8. Camí, J. and M. Farré, Mechanisms of disease: drug addiction. N Engl J Med, 2003. 349: pp. 975–986.

    Article  PubMed  Google Scholar 

  9. Miotto, K., et al., Diagnosing addictive disease in chronic pain patients. Psychosomatics, 1996. 37: pp. 223–235.

    PubMed  CAS  Google Scholar 

  10. Cherny, N.I., Opioid analgesics. Comparative features and prescribing guidelines. Drugs, 1996. 51: pp. 714–737.

    Article  Google Scholar 

  11. McLellan, A.T., et al., Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. JAMA, 2000. 284: pp. 1689–1695.

    Article  PubMed  CAS  Google Scholar 

  12. Fernandez, H.H., M.E. Trieschmann, and M.S. Okun, Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson’s disease. Mov Disord, 2005. 20: pp. 104–105.

    Article  PubMed  Google Scholar 

  13. Fossmark, R., et al., Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther, 2005. 21: pp. 149–154.

    Article  PubMed  CAS  Google Scholar 

  14. Barkin, R.L. and D. Barkin, Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection. South Med J, 2001. 94: pp. 756–770.

    PubMed  CAS  Google Scholar 

  15. Vastag, B., Addiction poorly understood by clinicians. Experts say attitudes, lack of knowledge hinder treatment. JAMA, 2003. 290: pp. 1299–1303.

    Article  PubMed  Google Scholar 

  16. Kendler, K.S., et al., Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiat, 2000. 57: pp. 261–269.

    Article  PubMed  CAS  Google Scholar 

  17. Jacob, T., et al., Genetic and environmental effects on offspring alcoholism. New insights using an offspring-of-twins design. Arch Gen Psychiat, 2003. 60: pp. 1265–12721.

    Article  PubMed  Google Scholar 

  18. Kreek, M.J., D.A. Nielson, and K.S. LaForge, Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med, 2004. 5: pp. 85–108.

    Article  PubMed  CAS  Google Scholar 

  19. Koob, G.F., et al., Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev, 2004. 27: pp. 739–749.

    Article  PubMed  CAS  Google Scholar 

  20. Simpson, D., et al., Screening for drugs of abuse (II): cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs. Ann Clin Biochem, 1997. 34: pp. 460–510.

    PubMed  CAS  Google Scholar 

  21. Wolff, K., et al., A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction, 1999. 94: pp. 1279–1298.

    Article  PubMed  CAS  Google Scholar 

  22. Girault, J.A. and P. Greengard, The neurobiology of dopamine signaling. Arch Neurol, 2004. 61: pp. 641–644.

    Article  PubMed  Google Scholar 

  23. Prescott, C.A. and K.S. Kendler, Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiat, 1999. 156: pp. 34–40.

    PubMed  CAS  Google Scholar 

  24. Enoch, M.A. and D. Goldman, The genetics of alcoholism and alcohol abuse. Curr Psychiatry Rep, 2001. 3: pp. 144–151.

    Article  PubMed  CAS  Google Scholar 

  25. Rhee, S.H., et al., Genetic and environmental influences on substance initiation, use, and problem use in adolescents. Arch Gen Psychiat, 2003. 60: pp. 1256–1264.

    Article  PubMed  Google Scholar 

  26. Uhl, G.R. and R.W. Grow, The burden of complex genetics in brain disorders. Arch Gen Psychiat, 2004. 61: pp. 223–229.

    Article  PubMed  Google Scholar 

  27. Toneatto, T., J.C. Negrete, and K. Calderwood, Diagnostic subgroups within a sample of comorbid substance abusers: correlates and characteristics. Am J Addict, 2000. 9: pp. 253–264.

    Article  PubMed  CAS  Google Scholar 

  28. Grant, B.F., et al., Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiat, 2004. 61: pp. 807–816.

    Article  PubMed  Google Scholar 

  29. Hasin, D., et al., Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiat, 2002. 59: pp. 375–380.

    Article  PubMed  Google Scholar 

  30. The National Center on Addiction and Substance Abuse at Columbia University. So Help Me God: Substance Abuse, Religion and Spirituality, 2001.

    Google Scholar 

  31. Schnoll, S.H. and J. Finch, Medical education for pain and addiction: making progress toward answering a need. J Law Med Ethics, 1994. 22: pp. 252–256.

    Article  PubMed  CAS  Google Scholar 

  32. Sj⊝gren, P., et al., Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain, 2000. 86: pp. 237–245.

    Article  PubMed  Google Scholar 

  33. Portenoy, R.K. and K.M. Foley, Chronic use of opioid analgesics in non-malignant pain. Report of 38 cases. Pain, 1986. 25: pp. 171–186.

    Article  PubMed  CAS  Google Scholar 

  34. Marsden, J., et al., Psychiatric symptoms among clients seeking treatment for drug dependence. Br J Psychiat, 2000. 176: pp. 285–289.

    Article  CAS  Google Scholar 

  35. American Academy of Pain Medicine and American Pain Society. The Use of Opioids for the Treatment of Chronic Pain. A Consensus Statement, 1996.

    Google Scholar 

  36. Compton, P., K. Darakjian, and K. Miotto, Screening for addiction in patients with chronic pain and “problematic” substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage, 1996. 16: pp. 355–363.

    Article  Google Scholar 

  37. Wilford, B.B., Abuse of prescription drugs in addiction medicine. West J Med, 1990. 152 (special issue): pp. 609–612.

    Google Scholar 

  38. Portenoy, R.K., Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage, 1996. 11: pp. 203–217.

    Article  PubMed  CAS  Google Scholar 

  39. Federation of State Medical Boards of the United States, I., Model Policy for the Use of Controlled Substances for the Treatment of Pain. 2004, A Policy Document of the Federation of State Medical Boards of the United States, Inc.

    Google Scholar 

  40. Heit, H.A., Creating and implementing opioid agreements. Care Management/Disease Management Digest, 2003. 7: pp. 2–3.

    Google Scholar 

  41. Drug Enforcement Administration. Physician’s Manual: An Informational Outline of the Controlled Substances Act of 1970, 1990. p. 21.

    Google Scholar 

  42. Weaver, M.F., M.A.E. Jarvis, and S.H. Schnoll, Role of the primary care physician in problems of substance abuse. Arch Intern Med, 1999. 159: pp. 913–924.

    Article  PubMed  CAS  Google Scholar 

  43. Lambert, L., Patients in pain need round-the-clock care. JAMA, 1999. 281: pp.689–692.

    Article  Google Scholar 

  44. American Pain Society. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis. Clinical Practice Guideline, Glenview, IL, 2002.

    Google Scholar 

  45. The Merck Manual of Diagnosis and Therapy. Vol. 17th edition, 1999.

    Google Scholar 

  46. Savage, S.R., Assessment for addiction in pain-treatment settings. Clin J Pain, 2002. 18: pp. S28–S38.

    Article  PubMed  Google Scholar 

  47. Fiellin, D.A., M.C. Reid, and P.G. O’Connor, Outpatient management of patients with alcohol problems. Ann Intern Med, 2000. 133: pp. 85–827.

    Google Scholar 

  48. Skinner, H.A., et al., Identification of alcohol abuse using laboratory tests and a history of trauma. Ann Intern Med., 1984. 101: pp. 847–851.

    PubMed  CAS  Google Scholar 

  49. Minovitz, O. and M. Driol, The sexual abuse, eating disorder and addiction (SEA) triad: syndrome or coincidence? Med Law, 1989. 8: pp. 59–61.

    PubMed  CAS  Google Scholar 

  50. Vastag, B., What’s the connection? No easy answers for people with eating disorders and drug abuse. JAMA, 2001. 285: pp. 1006–1007.

    Article  PubMed  CAS  Google Scholar 

  51. Ewing, J., Detecting alcoholism: the CAGE questionnaire. JAMA, 1984. 252: pp.1905–1907.

    Google Scholar 

  52. Fiellin, D.A., M.C. Reid, and P.G. O’Connor, Outpatient management of patients with alcohol problems. Ann Intern Med, 2000. 133: pp. 815–827.

    PubMed  CAS  Google Scholar 

  53. Bastiaens, L., G. Francis, and K. Lewis, The RAFFT as a screening tool for adolescent substance use disorders. Am J Addict, 2000. 9: pp. 10–16.

    Article  PubMed  CAS  Google Scholar 

  54. Knight, J.R., et al., Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med, 2002. 156: pp. 607–614.

    PubMed  Google Scholar 

  55. Sillanaukee, P. and U. Olsson, Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma-glutamyltransferase. Clin Chem, 2001. 47: pp. 681–685.

    PubMed  CAS  Google Scholar 

  56. Papoz, L., et al., Alcohol consumption in a healthy population. Relationship to gamma-glutamyl transferase activity and mean corpuscular volume. JAMA, 1981. 245: pp. 1748–1751.

    Article  PubMed  CAS  Google Scholar 

  57. Smith, K.E. and N.A. Fenske, Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol, 2000. 43: pp. 1–16.

    Article  PubMed  CAS  Google Scholar 

  58. Wiese, J.C., M.G. Shlipak, and W.S. Browner, The alcohol hangover. Ann Intern Med, 2000. 132: pp. 897–902.

    PubMed  CAS  Google Scholar 

  59. Shults, T.F., Medical Review Officer Handbook. Vol. 8th edition, 2002: Quadrangle Research.

    Google Scholar 

  60. Hammett-Stabler, C., A.J. Pesce, and D.J. Cannon, Urine drug screening in the medical setting. Clinica Chimica Acta, 2002. 315: pp. 125–135.

    Article  CAS  Google Scholar 

  61. Galloway, J.H. and I.D. Marsh, Detection of drug misuse—an addictive challenge. J Clin Pathol, 1999. 52: pp. 713–718.

    Article  PubMed  CAS  Google Scholar 

  62. Gourlay, D., H.A. Heit, and Y.H. Caplan, Urine Drug Testing in Clinical Practice: Dispelling the Myths and Designing Strategies [monograph]. 2004, Pharma Com Group, Inc: Stamford, CT.

    Google Scholar 

  63. Hattab, E.M., et al., Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposure. Ann Clin Lab Sci, 2000. 30: pp. 85–91.

    PubMed  CAS  Google Scholar 

  64. Passik, S.D., et al., A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influence patient management? J Pain Symtom Manage, 2000. 19: pp. 40–44.

    Article  CAS  Google Scholar 

  65. Perrone, J., et al., Drug screening versus history in detection of substance use in ED psychiatric patients. Am J Emerg Med, 2001. 19: pp. 49–51.

    Article  PubMed  CAS  Google Scholar 

  66. Braithwaite, R.A., et al., Screening for drugs of abuse. I: opiates, amphetamines and cocaine. Ann Clin Biochem, 1995. 32: pp. 123–153.

    PubMed  CAS  Google Scholar 

  67. Katz, N.P., Behavioral monitoring and urine toxicology testing in patients on long-term opioid therapy, in American Academy of Pain Medicine 17th Annual Meeting, 2001: Miami Beach, FL.

    Google Scholar 

  68. Savage, S., et al., Public policy statement on the rights and responsibilities of healthcare professionals in the use of opioids for the treatment of pain. A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine, 2004.

    Google Scholar 

  69. Vandevenne, M., H. Vandenbussche, and A. Verstraete, Detection time of drugs of abuse in urine. Acta Clinica Belgica, 2000. 55: pp. 323–333.

    PubMed  CAS  Google Scholar 

  70. Casavant, M.J., Urine drug screening in adolescents. Pediatr Clin N Am., 2002. 49: pp. 317–327.

    Article  Google Scholar 

  71. Cook, J.D., et al., The characterization of human urine for specimen validity determination in workplace drug testing: a review. J Anal Toxicol, 2000. 24:pp. 579–588.

    PubMed  CAS  Google Scholar 

  72. Rohrig, T.P. and C. Moore, The determination of morphine in urine and oral fluid following ingestions of poppy seeds. J Anal Toxicol, 2003. 27: pp. 449–452.

    PubMed  CAS  Google Scholar 

  73. Oyler, J.M., et al., Identification of hydrocodone in human urine following controlled codeine administration. J Anal Toxicol, 2000. 24: pp. 530–535.

    PubMed  CAS  Google Scholar 

  74. Wyeth-Ayerst, PROTONIX ® (pantoprazile sodium) package insert, 2004.

    Google Scholar 

  75. Casavant, M.J., Urine drug screening in adolescents. Pediatr Clin N Am, 2002. 49: pp. 317–327.

    Article  Google Scholar 

  76. Bosy, T.Z. and B.A. Cole, Consumption and quantitation of Δ9-tetrahydrocannabinol in commercially available hemp seed oil products. J Anal Toxicol, 2000. 24:pp. 562–566.

    Google Scholar 

  77. Leson, G., et al., Evaluating the impact of hemp food consumption on workplace drug tests. 2001; 25:691–698. J Anal Toxicol, 2001. 25: pp. 691–698.

    PubMed  CAS  Google Scholar 

  78. Baden, L.R., et al., Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA, 2001. 286: pp. 3115–3119.

    Article  PubMed  CAS  Google Scholar 

  79. Zacher, J.L. and D.M. Givone, False-positive urine opiate screening associated with fluoroquinolone use. Ann Pharmacother, 2004. 38: pp. 1525–1528.

    Article  PubMed  CAS  Google Scholar 

  80. Caplan, Y.H. and B.A. Goldberger, Alternative specimens for workplace drug testing. J Anal Toxicol., 2001. 25: pp. 396–399.

    PubMed  CAS  Google Scholar 

  81. Kintz, P. and N. Samyn, Use of alternative specimens: drugs of abuse in saliva and doping agents in hair. Ther Drug Monit, 2002. 24: pp. 239–246.

    Article  PubMed  CAS  Google Scholar 

  82. Yacoubian, G.S.J., E.D. Wish, and D.M. Pérez, A comparison of saliva testing to urinalysis in an arrestee population. J Psychoactive Drugs, 2001. 33: pp. 289–294.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heinrich-Heine-University, Düsseldorf, Germany

    Enno Freye

  2. University of the Pacific, Webster Street, San Francisco/California, USA

    Joseph Victor Levy

Authors
  1. Enno Freye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Victor Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Freye, E., Levy, J.V. (2008). Detection of Illicit Use of Opioids in Primary Care. In: Opioids in Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5947-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-5947-6_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-5946-9

  • Online ISBN: 978-1-4020-5947-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation